Assessment of proteinuria in pregnancy
BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39540.657928.BE (Published 01 May 2008) Cite this as: BMJ 2008;336:968- Lucy C Chappell, senior lecturer in maternal and fetal medicine,
- Andrew H Shennan, professor of obstetrics
- 1Division of Reproduction and Endocrinology, King’s College, London SE1 7EH
- lucy.chappell{at}kcl.ac.uk
Pre-eclampsia is a global problem—it affects 2-8% of pregnancies, and an estimated 8.3 million women develop the disease each year. For developing countries, the priority is preventing maternal deaths from multiorgan complications of the disease. The difference in case fatality rates from eclampsia between developing countries and developed countries (5.2% v 0.72%) suggests that mortality is easily avoidable.1 In developed countries where death is rarer, research is directed towards improving prediction and prevention of pre-eclampsia and minimising morbidity. Accurate diagnosis is needed to accomplish this. In the accompanying systematic review, Côté and colleagues assess urinary spot protein:creatinine and albumin:creatinine ratios as diagnostic tests for significant proteinuria in women with hypertension in pregnancy.2
Pre-eclampsia is a multiorgan syndrome, the clinical characteristics of which may include kidney, liver, and cerebral damage, an altered coagulant state, and fetal growth restriction.3 It is defined by two imperfect measures of end organ involvement—hypertension and proteinuria.4 Early blood markers of the disease can now be identified many weeks before these clinical manifestations,5 but antenatal diagnosis still relies on measuring blood pressure and urine …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.